Paladin Advisory Group, LLC - LUMOS PHARMA INC ownership

LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 38 filers reported holding LUMOS PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Paladin Advisory Group, LLC ownership history of LUMOS PHARMA INC
ValueSharesWeighting
Q3 2023$14,4770.0%4,3870.0%0.01%0.0%
Q2 2023$14,477
-0.3%
4,3870.0%0.01%0.0%
Q1 2023$14,521
-8.3%
4,3870.0%0.01%
-14.3%
Q4 2022$15,837
-58.3%
4,387
+0.1%
0.01%
-60.0%
Q3 2022$38,000
+15.2%
4,3820.0%0.04%
+25.0%
Q2 2022$33,000
-17.5%
4,3820.0%0.03%
-15.2%
Q1 2022$40,000
+33.3%
4,3820.0%0.03%
+37.5%
Q4 2021$30,0004,3820.02%
Other shareholders
LUMOS PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 407,192$5,627,0001.23%
Opaleye Management Inc. 240,892$3,329,0000.65%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 936,291$12,940,0000.32%
NEA Management Company, LLC 526,663$7,278,0000.31%
Investors Financial Group, LLC 21,766$301,0000.22%
Wealth Advisors of Iowa, LLC 11,760$163,0000.11%
Blackstone Inc. 468,145$6,470,0000.02%
Jefferies Group LLC 120,651$1,667,0000.02%
Texas Yale Capital Corp. 16,000$221,0000.02%
Prospera Financial Services Inc 1,088$15,0000.01%
View complete list of LUMOS PHARMA INC shareholders